It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"If Novartis gets through with its case our lives are at risk," Monique Wanjala, a woman who has been living with HIV for 13 years, told a news conference in Nairobi. "We want this case dropped," she said. "If we die because affordable generic drugs aren't available, where will they sell the drug? If profits are going to be put before peoples' lives then we have a serious problem."
Originally posted by carslake
Novartis charges $10,000 per annum for its anti-retroviral drug, whereas India manufactures it for $70 per annum. Is it me or is Novartis making $9930 on every patient taking its treatment, can anyone justify that level of profit.